Home » Topics » Regulatory » EMA

EMA
RSS

Ariad receives FDA feedback on pivotal study of AP-23573 for metastatic sarcoma

April 11, 2007

Lilly withdraws E.U. marketing authorization application for Arxxant

April 10, 2007

EMEA recommends restrictions on use of Ketek

April 4, 2007

Orencia recommended for approval in E.U. for rheumatoid arthritis

April 2, 2007

European CHMP hands down positive opinions for Xyrem and Prevenar

Jan. 30, 2007

Sprycel approved in E.U.

Dec. 1, 2006

Microdosing/phase 0 trials: Paradigm shift aims to speed new drug development, improve efficiency

Nov. 7, 2006

Aldara recommended for approval for actinic keratosis in Europe

Oct. 23, 2006

Positive opinion handed down in Europe for new Glivec indication

Oct. 23, 2006

Europe's CHMP recommends Hycamtin for new indication

Oct. 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...